USA flag logo/image

An Official Website of the United States Government

REAL-TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
60314
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
HL070360
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BCR DIAGNOSTICS, INC.
1123 E. THUNDERHILL PL PHOENIX, AZ 85048-
View profile »
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: REAL-TIME DETECTION OF BACTERIA IN PLATELET CONCENTRATES
Agency: HHS
Contract: 1R43HL070360-01
Award Amount: $136,210.00
 

Abstract:

DESCRIPTION (Provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to demonstrate the feasibility of adapting its LEXSAS (Label-free Exponential Signal-Amplification System) technology for real-time bacteriologic analysis of blood products intended for transfusion. The LEXSAS technology is unique in that it uses spores as ultrasensitive nanodevices capable of emitting fluorescent light signals when encountering single bacterial cells. This extraordinary ability is due to integrated spore mechanisms for sensing/transducing/amplifying discrete biomolecular signals in the milieu. Based on theoretical considerations and preliminary studies, BCR expects that the biosensor will have the following specifications: ability to detect a single bacterium; ability to yield quantitative results in less than 60 minutes; minimal sample preparation; no labeling reagents (such as fluorescent, radioisotopic or enzymatic reporter molecules) are required; linear detection response over a wide dynamic range of one to 10E6 bacteria per ml; single use (disposable), low manufacturing cost; and applicability to automated high-throughput operations. A real-time bacteriological biosensor should have a major impact not only in making transfusions safer for patients, but also in the financial aspects of blood banking. PROPOSED COMMERCIAL APPLICATION: BCR's real-time bacteriologic biosaensor would have a critical impact in public health and other major industries now relying on culture-based testing that usually requires 16-48 hours for completion. Potential commercial applications of the technology include: (1) clinical diagnostics; (2) bioterrorism defense; (3) screening food and beverages; (4) environmental monitoring (air and water); (5) sterility testing; and (6) screening blood products intended for transfusion.

Principal Investigator:

Boris Rotman
4018499957
ROTMAN@BCRBIOTECH.COM

Business Contact:

Rosario Guzman
4014232017
WWW.BRCBIOTECH.COM
Small Business Information at Submission:

BCR DIAGNOSTICS
BCR DIAGNOSTICS 1062 EAST SHORE RD JAMESTOWN, RI 02835

EIN/Tax ID: 050416591
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No